Thomas Golper, MD
Nephrology · Nashville, TNNPI 1043229495
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $19,211 of the $25,820 with a category attached, or 74.4%. 6 manufacturers reported payments, led by Nxstage Medical, Inc. at 52.0% of the total. Reporting peaked in 2020 at $13,206 and has fallen 98.2% since, to $236 in 2023. Among nephrology clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 41 payments — averaging $629.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nxstage Medical, Inc.$13K
- Mallinckrodt Hospital Products Inc.$7K
- Fresenius USA Marketing, Inc.$5K
- W. L. Gore & Associates, Inc.$290
- Quanta Dialysis Technologies Inc$236
- Vifor Pharma, Inc.$200
Across 1 payment — averaging $11,700 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Fresenius USA Marketing, Inc.$12K
What the payments were for
- Consulting fees$19,21174%
- Speaking & faculty fees$2,69910%
- Travel & lodging$2,2219%
- Food & beverage$9774%
- Gifts$4752%
- Entertainment$2361%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nxstage Medical, Inc. | 26 | $13,429 |
| Mallinckrodt Hospital Products Inc. | 1 | $6,750 |
| Fresenius USA Marketing, Inc. | 10 | $4,915 |
| W. L. Gore & Associates, Inc. | 1 | $290 |
| Quanta Dialysis Technologies Inc | 2 | $236 |
| Vifor Pharma, Inc. | 1 | $200 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- System One$6,792
- NXSTAGE SYSTEM ONE$6,171
- Product in Development$290
- Veltassa$200
- SC+ Hemodialysis Machine$199
How this compares
$25,820 in reported general payments places this provider in the 90th percentile of 229 nephrology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Calcium Acetate | 16 | $1,280 |
| Torsemide | 15 | $354 |
| Nystatin | 13 | $316 |
| Furosemide | 16 | $309 |
| Carvedilol | 16 | $157 |
| Doxazosin Mesylate | 11 | $155 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Nashville
- Jamie DwyerNashville$461K
- Volker HaaseNashville$123K
- Talat IkizlerNashville$93K
- Julia LewisNashville$87K
- Osama El ShamyNashville$87K
- Anthony LangoneNashville$23K
- James LutherNashville$20K
- Jeffrey HymesNashville$19K
- Roy ZentNashville$17K
- Alfred GeorgeNashville$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.